Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cleomiscosin C has antioxidant activity, it protects against the oxidative modification of apoB-100 induced by either Cu2+ or HOCl ( IC50s of 23.6 and 3.9 microM, respectively), suggests that it could be beneficial in preventing LDL oxidation in atherosclerotic lesions. Cleomiscosins A, B and C exhibit liver-protective properties.
説明 | Cleomiscosin C has antioxidant activity, it protects against the oxidative modification of apoB-100 induced by either Cu2+ or HOCl ( IC50s of 23.6 and 3.9 microM, respectively), suggests that it could be beneficial in preventing LDL oxidation in atherosclerotic lesions. Cleomiscosins A, B and C exhibit liver-protective properties. |
植物由来 |
分子量 | 416.38 |
分子式 | C21H20O9 |
CAS No. | 84575-10-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cleomiscosin C 84575-10-0 Metabolism LDL Inhibitor inhibitor inhibit